Protara Therapeutics (TARA) Earnings Date & Reports

A.I. Advisor

published Earnings

TARA is expected to report earnings to rise 11.11% to -50 cents per share on October 31

Protara Therapeutics TARA Stock Earnings Reports

Q3'24

Est.

$-0.50

Q2'24

Beat

by $0.29

Q1'24

Missed

by $0.06

Q4'23

Beat

by $0.02

Q3'23

Beat

by $0.11

The last earnings report on August 06 showed earnings per share of -44 cents, beating the estimate of -74 cents. With 84.91K shares outstanding, the current market capitalization sits at 38.99M.

View a ticker or compare two or three

Compare

TARA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For TARA
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage company, which engages in developing treatments for rare and specialty diseases with significant unmet needs.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

345 Park Avenue South

Phone

+1 646 844-0337

Employees

Web

http://www.protaratx.com